Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
β Cell tone is defined by proglucagon peptides through cAMP signaling
Megan E. Capozzi, … , David A. D’Alessio, Jonathan E. Campbell
Megan E. Capozzi, … , David A. D’Alessio, Jonathan E. Campbell
Published February 5, 2019
Citation Information: JCI Insight. 2019;4(5):e126742. https://doi.org/10.1172/jci.insight.126742.
View: Text | PDF
Research Article Endocrinology Metabolism

β Cell tone is defined by proglucagon peptides through cAMP signaling

  • Text
  • PDF
Abstract

Paracrine interactions between pancreatic islet cells have been proposed as a mechanism to regulate hormone secretion and glucose homeostasis. Here, we demonstrate the importance of proglucagon-derived peptides (PGDPs) for α to β cell communication and control of insulin secretion. Signaling through this system occurs through both the glucagon-like peptide receptor (Glp1r) and glucagon receptor (Gcgr). Loss of PGDPs, or blockade of their receptors, decreases insulin secretion in response to both metabolic and nonmetabolic stimulation of mouse and human islets. This effect is due to reduced β cell cAMP and affects the quantity but not dynamics of insulin release, indicating that PGDPs dictate the magnitude of insulin output in an isolated islet. In healthy mice, additional factors that stimulate cAMP can compensate for loss of PGDP signaling; however, input from α cells is essential to maintain glucose tolerance during the metabolic stress induced by high-fat feeding. These findings demonstrate an essential role for α cell regulation of β cells, raising the possibility that abnormal paracrine signaling contributes to impaired insulin secretion in diabetes. Moreover, these findings support reconsideration of the role for α cells in postprandial glucose control.

Authors

Megan E. Capozzi, Berit Svendsen, Sara E. Encisco, Sophie L. Lewandowski, Mackenzie D. Martin, Haopeng Lin, Justin L. Jaffe, Reilly W. Coch, Jonathan M. Haldeman, Patrick E. MacDonald, Matthew J. Merrins, David A. D’Alessio, Jonathan E. Campbell

×

Figure 1

Proglucagon products stimulate insulin secretion through both the Glp1r and Gcgr.

Options: View larger image (or click on image) Download as PowerPoint
Proglucagon products stimulate insulin secretion through both the Glp1r ...
(A) Insulin secretion in response to increasing doses of glucagon in control (Con; MIP-CreERT) or Gcgrβcell–/– islets with or without 1 μM exendin 9–39 (Ex9) (Con, Gcgrβcell–/–, Con + Ex9, Gcgrβcell–/– + Ex9; n = 9, 8, 3, 7). (B) Insulin secretion in response to increasing doses of glucagon from Con or Glp1rβcell–/– islets with or without 10 μg/ml GRA (Con, Con + GRA, Glp1rβcell–/–, Glp1rβcell–/– + GRA; n = 6, 6, 5, 5). (C) Glucagon and total GLP-1 secretion in response to 10 mM glutamine and 1 mM arginine (n = 3). (D) Insulin secretion in response to 10 mM glutamine and 1 mM arginine from Con or Gcgrβcell–/– islets treated with 1 μM Ex9 (n = 6). (E) Insulin secretion in response to 10 mM glutamine and 1 mM arginine from WT or Glp1rβcell–/– islets treated with 10 μg/ml GRA (n = 5). *P < 0.05. Data are shown as mean ± SEM. Data were analyzed with a 2-way ANOVA for the iAUCs (A, B, D, and E) or a 2-tailed Student’s t test (C).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts